Low dose aspirin may not be effective for heart disease in diabetes patients. Two studies published in the The Journal of the American Medical Association have claimed it. The researchers aren’t closing the door on aspirin for diabetes patients. However, they suggest that the decision to prescribe aspirin should be made on an individual patient basis.
One of the studies, published in The Journal of the American Medical Association, took place in Japan and included 2,539 adults with type 2 diabetes who typically stayed in the study for about four years.The other study, published last month in BMJ’s “Online First” edition, took place in Scotland and included 1,276 adults with type 1 or type 2 diabetes who were followed for about six years.But in both studies, the bottom line was the same: There was no sign that taking low-dose aspirin lessened the patients’ odds of having their first cardiovascular event.
But in The Journal of the American Medical Association, editorialist Antonio Nicolucci, MD, of Italy’s Consorzio Mario Negri Sud encourages doctors and diabetes patients to weigh the pros and cons of low-dose aspirin on a case-by-case basis until further research is available.